{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:58:44Z","timestamp":1791241124877,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Clostridioides difficile<\/jats:italic>\n                      infection (CDI) caused by epidemic ribotype 027 strains has been associated with increased morbidity and mortality. However, many studies evaluating outcomes have been limited due to small sample size and inclusion of only one facility.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using a nationwide cohort of hospitalized patients in the Veterans Health System, we conducted a retrospective cohort study to examine the impact of infection with the 027 strain on severity of illness and recurrence in adults treated for CDI between October 2009 and September 2020. Cases of infection due to ribotype 027 were compared to control infections due to non-027 strains after balancing on patient characteristics using propensity score matching. Outcomes included recurrence of CDI, severe illness, and mortality at 14, 30, and 90 days after diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In the unadjusted analysis, infection with ribotype 027 was associated with increased odds of recurrence and intensive care unit admission, severe CDI, colectomy, and death. For propensity score matching, 3709 cases of CDI due to ribotype 027 were successfully matched to 11,127 controls. After matching, infection with the ribotype 027 strain was only linked to increased risk of CDI recurrence (14.9% versus 10.5%, OR\u2009=\u20091.7, 95% CI, 1.55\u20131.86).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>After propensity score matching, we found that infection with the ribotype 027 strain was associated with recurrence of CDI, but not with increased severity of illness or mortality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-13997-x","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T08:55:33Z","timestamp":1783673733000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of the ribotype 027 strain on Clostridioides difficile infection outcomes and recurrence in the Veterans Affairs healthcare system: a propensity scores matching study"],"prefix":"10.1186","volume":"26","author":[{"given":"Sandra Y.","family":"Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigid M.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis J.","family":"Donskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"13997_CR1","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1056\/NEJMoa051639","volume":"353","author":"VG Loo","year":"2005","unstructured":"Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353:2442\u20139.","journal-title":"N Engl J Med"},{"key":"13997_CR2","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1056\/NEJMoa051590","volume":"353","author":"LC McDonald","year":"2005","unstructured":"McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005;353:2433\u201341.","journal-title":"N Engl J Med"},{"key":"13997_CR3","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3201\/eid2602.181965","volume":"26","author":"AM Skinner","year":"2020","unstructured":"Skinner AM, Petrella L, Siddiqui F, Sambol SP, Gulvik CA, Gerding DN, Donskey CJ, Johnson S. Unique Clindamycin-Resistant Clostridioides difficile Strain Related to Fluoroquinolone-Resistant Epidemic BI\/RT027 Strain. Emerg Infect Dis. 2020;26:247\u201354.","journal-title":"Emerg Infect Dis"},{"key":"13997_CR4","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S1473-3099(17)30052-X","volume":"17","author":"CJ Donskey","year":"2017","unstructured":"Donskey CJ. Fluoroquinolone restriction to control fluoroquinolone-resistant Clostridium difficile. Lancet Infect Dis. 2017;17:353\u20134.","journal-title":"Lancet Infect Dis"},{"key":"13997_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S1473-3099(16)30514-X","volume":"17","author":"KE Dingle","year":"2017","unstructured":"Dingle KE, Didelot X, Phuong Quan T, et al. Effects of control interventions on Clostridium difficile infection in England: an observational study. Lancet Infect Dis. 2017;17:411\u201321.","journal-title":"Lancet Infect Dis"},{"key":"13997_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1017\/ice.2020.383","volume":"42","author":"SY Silva","year":"2021","unstructured":"Silva SY, Wilson BM, Redmond SN, Donskey CJ. Inpatient fluoroquinolone use in Veterans\u2019 Affairs hospitals is a predictor of Clostridioides difficile infection due to fluoroquinolone-resistant ribotype 027 strains. Infect Control Hosp Epidemiol. 2021;42:57\u201362.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"13997_CR7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/cid\/civ254","volume":"61","author":"K Rao","year":"2015","unstructured":"Rao K, Micic D, Natarajan M, et al. Clostridium difficile ribotype 027: relationship to age, detectability of toxins A or B in stool with rapid testing, severe infection, and mortality. Clin Infect Dis. 2015;61:233\u201341.","journal-title":"Clin Infect Dis"},{"key":"13997_CR8","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1093\/cid\/ciu125","volume":"58","author":"I See","year":"2014","unstructured":"See I, Mu Y, Cohen J, et al. NAP1 strain type predicts outcomes from Clostridium difficile infection. Clin Infect Dis. 2014;58:1394\u2013400.","journal-title":"Clin Infect Dis"},{"key":"13997_CR9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1093\/cid\/cis430","volume":"55","author":"LA Petrella","year":"2012","unstructured":"Petrella LA, Sambol SP, Cheknis A, et al. Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain. Clin Infect Dis. 2012;55:351\u20137.","journal-title":"Clin Infect Dis"},{"key":"13997_CR10","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1093\/cid\/cit127","volume":"56","author":"AS Walker","year":"2013","unstructured":"Walker AS, Eyre DW, Wyllie DH, et al. Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection. Clin Infect Dis. 2013;56:1589\u2013600.","journal-title":"Clin Infect Dis"},{"key":"13997_CR11","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1017\/ice.2015.187","volume":"36","author":"SL Aitken","year":"2015","unstructured":"Aitken SL, Alam MJ, Khaleduzzaman M, et al. In the endemic setting, Clostridium difficile ribotype 027 is virulent but not hypervirulent. Infect Control Hosp Epidemiol. 2015;36:1318\u201323.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"13997_CR12","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1093\/cid\/cis786","volume":"55","author":"ST Walk","year":"2012","unstructured":"Walk ST, Micic D, Jain R, Lo ES, et al. Clostridium difficile ribotype does not predict severe infection. Clin Infect Dis. 2012;55:1661\u20138.","journal-title":"Clin Infect Dis"},{"key":"13997_CR13","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1017\/ice.2014.45","volume":"36","author":"T Scardina","year":"2015","unstructured":"Scardina T, Labuszewski L, Pacheco SM, Adams W, Schreckenberger P, Johnson S. Clostridium difficile infection (CDI) severity and outcome among patients infected with the NAP1\/BI\/027 strain in a non-epidemic setting. Infect Control Hosp Epidemiol. 2015;36:280\u20136.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"13997_CR14","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jinf.2011.03.001","volume":"62","author":"SD Goldenberg","year":"2011","unstructured":"Goldenberg SD, French GL. Lack of association of tcdC type and binary toxin status with disease severity and outcome in toxigenic Clostridium difficile. J Infect. 2011;62:355\u201362.","journal-title":"J Infect"},{"key":"13997_CR15","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.1128\/JCM.05053-11","volume":"49","author":"S Sirard","year":"2011","unstructured":"Sirard S, Valiquette L, Fortier LC. Lack of association between clinical outcome of Clostridium difficile infections, strain type, and virulence-associated phenotypes. J Clin Microbiol. 2011;49:4040\u20136.","journal-title":"J Clin Microbiol"},{"key":"13997_CR16","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1093\/cid\/civ749","volume":"61","author":"CN Abou Chakra","year":"2015","unstructured":"Abou Chakra CN, McGeer A, Labb\u00e9 AC, et al. Factors Associated With Complications of Clostridium difficile Infection in a Multicenter Prospective Cohort. Clin Infect Dis. 2015;61:1781\u20138.","journal-title":"Clin Infect Dis"},{"key":"13997_CR17","doi-asserted-by":"publisher","first-page":"ofae085","DOI":"10.1093\/ofid\/ofae085","volume":"11","author":"CN Abou Chakra","year":"2024","unstructured":"Abou Chakra CN, Gagnon A, Lapointe S, Granger MF, L\u00e9vesque S, Valiquette L. The Strain and the Clinical Outcome of Clostridioides difficile Infection: A Meta-analysis. Open Forum Infect Dis. 2024;11:ofae085.","journal-title":"Open Forum Infect Dis"},{"key":"13997_CR18","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1177\/0962280219899248","volume":"29","author":"PC Austin","year":"2020","unstructured":"Austin PC. Advances in propensity score analysis. Stat Methods Med Res. 2020;29:641\u20133.","journal-title":"Stat Methods Med Res"},{"issue":"Suppl 1","key":"13997_CR19","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1086\/521859","volume":"46","author":"RC Owens Jr","year":"2008","unstructured":"Owens RC Jr, Donskey CJ, Gaynes RP, Loo VG, Muto CA. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis. 2008;46(Suppl 1):S19\u201331.","journal-title":"Clin Infect Dis"},{"key":"13997_CR20","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1093\/cid\/cir404","volume":"53","author":"KM Mullane","year":"2011","unstructured":"Mullane KM, Miller MA, Weiss K, et al. Efficacy of fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infections. Clin Infect Dis. 2011;53:440\u20137.","journal-title":"Clin Infect Dis"},{"key":"13997_CR21","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1017\/ice.2023.18","volume":"44","author":"LK Kociolek","year":"2023","unstructured":"Kociolek LK, Gerding DN, Carrico R, et al. Strategies to prevent Clostridioides difficile infections in acute-care hospitals: 2022 Update. Infect Control Hosp Epidemiol. 2023;44:527\u201349.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"13997_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","volume":"70","author":"PR Rosenbaum","year":"1983","unstructured":"Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41\u201355.","journal-title":"Biometrika"},{"key":"13997_CR23","doi-asserted-by":"publisher","first-page":"5565","DOI":"10.1002\/sim.9141","volume":"40","author":"PC Austin","year":"2021","unstructured":"Austin PC, Rubin DB, Thomas N. Estimating adjusted risk differences by multiply-imputing missing control binary potential outcomes following propensity score-matching. Stat Med. 2021;40:5565\u201386.","journal-title":"Stat Med"},{"key":"13997_CR24","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s11739-015-1366-6","volume":"11","author":"S Khanna","year":"2016","unstructured":"Khanna S, Gupta A, Baddour LM, Pardi DS. Epidemiology, outcomes, and predictors of mortality in hospitalized adults with Clostridium difficile infection. Intern Emerg Med. 2016;11:657\u201365.","journal-title":"Intern Emerg Med"},{"key":"13997_CR25","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10654-018-0415-7","volume":"34","author":"G Li","year":"2019","unstructured":"Li G, Lip GY, Holbrook A, Chang Y, Larsen TB, Sun X, Tang J, Mbuagbaw L, Witt DM, Crowther M, Thabane L. Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies. Europ J Epidemiol. 2019;34:173\u201390.","journal-title":"Europ J Epidemiol"},{"key":"13997_CR26","doi-asserted-by":"publisher","first-page":"e0340825","DOI":"10.1128\/spectrum.03408-25","volume":"14","author":"AM Skinner","year":"2026","unstructured":"Skinner AM, Guh AY, Petrella LA, et al. Clostridioides difficile clinical diagnostic test methods and results are associated with recovery of C. difficile by stool culture. Microbiol Spectr. 2026;14:e0340825.","journal-title":"Microbiol Spectr"},{"key":"13997_CR27","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s10096-013-2043-1","volume":"33","author":"JH Boone","year":"2014","unstructured":"Boone JH, Archbald-Pannone LR, Wickham KN, Carman RJ, Guerrant RL, Franck CT, Lyerly DM. Ribotype 027 Clostridium difficile infections with measurable stool toxin have increased lactoferrin and are associated with a higher mortality. Eur J Clin Microbiol Infect Dis. 2014;33:1045\u201351.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"13997_CR28","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1093\/cid\/ciz009","volume":"69","author":"AY Guh","year":"2019","unstructured":"Guh AY, Hatfield KM, Winston LG, et al. Toxin enzyme immunoassays detect Clostridioides difficile infection with greater severity and higher recurrence rates. Clin Infect Dis. 2019;69:1667\u201374.","journal-title":"Clin Infect Dis"},{"key":"13997_CR29","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1080\/22221751.2022.2105260","volume":"11","author":"F Anwar","year":"2022","unstructured":"Anwar F, Roxas BAP, Shehab KW, Ampel NM, Viswanathan VK, Vedantam G. Low-toxin Clostridioides difficile RT027 strains exhibit robust virulence. Emerg Microbes Infect. 2022;11:1982\u201393.","journal-title":"Emerg Microbes Infect"},{"key":"13997_CR30","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/cid\/ciw758","volume":"64","author":"AF Widmer","year":"2017","unstructured":"Widmer AF, Frei R, Erb S, Stranden A, Kuijper EJ, Knetsch CW, Tschudin-Sutter S. Transmissibility of Clostridium difficile Without Contact Isolation: Results From a Prospective Observational Study With 451 Patients. Clin Infect Dis. 2017;64:393\u2013400.","journal-title":"Clin Infect Dis"},{"key":"13997_CR31","doi-asserted-by":"publisher","first-page":"e497","DOI":"10.1093\/cid\/ciaa169","volume":"71","author":"J Amoah","year":"2020","unstructured":"Amoah J, Stuart EA, Cosgrove SE, Harris AD, Han JH, Lautenbach E, Tamma PD. Comparing propensity score methods versus traditional regression analysis for the evaluation of observational data: A case study evaluating the treatment of gram-negative bloodstream infections. Clin Infect Dis. 2020;71:e497\u2013505.","journal-title":"Clin Infect Dis"},{"key":"13997_CR32","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1017\/ice.2018.106","volume":"39","author":"CJ Donskey","year":"2018","unstructured":"Donskey CJ, Sunkesula VCK, Stone ND, Gould CV, McDonald LC, Samore M, Mayer J, Pacheco SM, Jencson AL, Sambol SP, Petrella LA, Gulvik CA, Gerding DN. Transmission of Clostridium difficile from asymptomatically colonized or infected long-term care facility residents. Infect Control Hosp Epidemiol. 2018;39:909\u201316.","journal-title":"Infect Control Hosp Epidemiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13997-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13997-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13997-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:44:54Z","timestamp":1791240294000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13997-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13997"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13997-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was submitted to, and approved by, the Louis Stokes Cleveland VA Medical Center\u2019s Institutional Review Board (Protocol #1583880). Informed consent was not obtained as the need for informed consent to participate was waived by the Louis Stokes Cleveland VA Medical Center\u2019s Institutional Review Board. The research adhered to the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"C.J.D has received research grants from Clorox and Ushio America unrelated to the current study. All other authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1773"}}